{"name":"Korea Arlico Pharm. Co., Ltd","slug":"korea-arlico-pharm-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"ALC-2203-1","genericName":"ALC-2203-1","slug":"alc-2203-1","indication":"Other","status":"phase_2"},{"name":"ALC-2203-2","genericName":"ALC-2203-2","slug":"alc-2203-2","indication":"Treatment of inflammatory diseases","status":"phase_2"}]},{"name":"Pain","slug":"pain","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"ALC-2203-AC","genericName":"ALC-2203-AC","slug":"alc-2203-ac","indication":"Chronic pain","status":"phase_2"}]}],"pipeline":[{"name":"ALC-2203-1","genericName":"ALC-2203-1","slug":"alc-2203-1","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"ALC-2203-2","genericName":"ALC-2203-2","slug":"alc-2203-2","phase":"phase_2","mechanism":"ALC-2203-2 is a selective and potent agonist of the GPR84 receptor.","indications":["Treatment of inflammatory diseases"],"catalyst":""},{"name":"ALC-2203-AC","genericName":"ALC-2203-AC","slug":"alc-2203-ac","phase":"phase_2","mechanism":"ALC-2203-AC is a selective and potent agonist of the kappa opioid receptor.","indications":["Chronic pain"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMihAFBVV95cUxNZmRFZFZZSW01MllsMTFBSEdtUmlyYmxrd3VCcVFydFlmV0RmY0FBMDFKaWFJbDY5TXQyd0dQQzd2eDlLVXVKMXVRd1VQZXFNV0RGZDdxc18wTnhGYkJON0ljNmFmZlpsSnNFNVJfRUZaNUc2a25peWNkVmhGdzlZb3pYeUw?oc=5","date":"2020-05-19","type":"pipeline","source":"Yahoo Finance UK","summary":"Will Korea Arlico Pharm Co's (KOSDAQ:260660) quality and momentum help its shareholders? - Yahoo Finance UK","headline":"Will Korea Arlico Pharm Co's (KOSDAQ:260660) quality and momentum help its shareholders?","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE5VUHBoU1Y3MnIwSkpOVTRsNElxc3hSMEt3Vzk2VUJwMVJjVms3SWdKdTNlTjFDelhBT1FCVDNvZTFSLXNScm9NS19mN29ZeXlDOXRHMTV4Tm0yU24zOE43SXJFN1hzMzk4VzVPRtIBcEFVX3lxTE1sYkt0bjNXNHNQVmlGN3FsYll6NlN5X0pNejl5UEpKbDdHdF9Pb3ltLUhORExiLUJYZFFpWU1BX1hva0Vqb01GeHBCRTBuMHFUbzFyVmVRbHdEaEFJcjlfZFIyaXFra0VRdWpkcmFyQzg?oc=5","date":"2019-02-01","type":"patent","source":"koreabiomed.com","summary":"14 pharmaceuticals to release gastritis generic drugs soon - koreabiomed.com","headline":"14 pharmaceuticals to release gastritis generic drugs soon","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE1zREE4Z2dyaW9zNnFsUXZwR2hacnIwSWpFdV9mdmxkd0lKSlVTQWpvVzYzSjRFTjFPSktlSkFMeWtaaGwzVUVEc1JTYVRUcHY0a3hHeFkzam04MlFuekV6RDh1bHRSSWt6Zk1jZtIBcEFVX3lxTE16b0Y4VFRSZTVRbVFuUHBPQ3kxRHF5M0lzNU5JTUdIX0dUTU5MMTZJVVZDNTRyZDFnQlVOMWRNdU5tVGJJRGxhQ2NGZi02U2xMTjNObF9CbHp6XzNsTWUtSm50ZFBEaXFxaXBwVWd2RzE?oc=5","date":"2019-01-14","type":"patent","source":"koreabiomed.com","summary":"14 drugmakers to release generic copies of Stillen 2X in early February - koreabiomed.com","headline":"14 drugmakers to release generic copies of Stillen 2X in early February","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_2":3},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}